Multicell Competitors

Pink Sheets USA . 
Stock . Multicell Techs
Multicell Techs competes with Pmv Pharmaceuticals, MediciNova, Pharvaris, PepGen, and Anebulo Pharmaceuticals; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Multicell Techs competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Multicell Techs to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Multicell Techs Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Multicell Techs competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Multicell Techs' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Multicell Techs Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Multicell Techs and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Multicell and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Multicell Techs does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
AVTE
+ 0.74
PMVP
ANEB
+ 0.74
PEPG
RZLT
+ 0.72
PMVP
MOLN
+ 0.69
PMVP
ADAG
+ 0.64
MOLN
MOLN
+ 0.61
PHVS
  
High negative correlations   
AVTE
- 0.87
PEPG
AVTE
- 0.69
ANEB
PEPG
- 0.63
PMVP
ANEB
- 0.51
PMVP
ADAG
- 0.47
MNOV
PEPG
- 0.45
PHVS

Risk-Adjusted Indicators

There is a big difference between Multicell Pink Sheet performing well and Multicell Techs Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Multicell Techs' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PMVP  1.66  0.00 (0.02) 0.10  2.11 
(2.03)
 4.32 
(4.43)
 13.98 
MNOV  4.83  1.19  0.16 (0.36) 4.29 
(6.59)
 12.43 
(8.50)
 61.30 
PHVS  3.08  0.06  0.03  0.14  3.78 
(3.60)
 7.76 
(7.49)
 23.21 
PEPG  3.43 (0.63) 0.00 (0.39) 0.00 
 0.00 
 6.69 
(9.02)
 26.81 
ANEB  4.90 (0.11)(0.01) 0.02  7.16 
(5.82)
 8.61 
(11.48)
 76.00 
RZLT  2.83  0.11  0.04  0.18  3.11 
(3.27)
 6.80 
(5.54)
 30.01 
HCWB  13.27  3.57  0.31 (0.98) 8.38 
(22.88)
 22.00 
(16.67)
 352.85 
MOLN  4.36  0.01  0.01  0.11  4.65 
(5.93)
 9.38 
(7.22)
 52.92 
AVTE  2.39  0.42  0.16  0.54  2.09 
(3.24)
 5.58 
(3.86)
 19.11 
ADAG  4.50 (0.12) 0.00 (0.34) 0.00 
 0.00 
 8.13 
(9.52)
 37.93 
All Fundamental Data

Multicell Techs Competitive Analysis

The better you understand Multicell Techs competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Multicell Techs' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Multicell Techs' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
PMVP MNOV PHVS PEPG ANEB RZLT HCWB MOLN AVTE ADAG
 4.35 
 1.68 
Pmv
 1.74 
 2.26 
MediciNova
 1.11 
 20.00 
Pharvaris
 5.35 
 6.01 
PepGen
 7.64 
 1.55 
Anebulo
 3.55 
 5.16 
Rezolute
 8.70 
 0.42 
HCW
 5.81 
 5.83 
Molecular
 2.67 
 2.55 
Aerovate
 6.01 
 2.19 
Adagene
Market Volatility
(90 Days Market Risk)
Slightly risky
Risky
Not too volatile
Slightly risky
Dangerous
Moderately volatile
Out of control
Unstable
Somewhat reliable
Unstable
Market Performance
(90 Days Performance)
Insignificant
Modest
Weak
Very Weak
Weak
OK
Modest
Weak
Good
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Above Average
Below Average
About Average
Below Average
Low
Low
High
Low
Low
About Average
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Hold
Buy
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Buy
Strong Sell
Current Ratio
24.76
17.17
12.85
11.01
30.4
61.78
30.25
14.37
40.85
3.1
Net Asset
252.15 M
66.27 M
398.69 M
143.05 M
4.07 M
132.74 M
28.51 M
198.35 M
127.42 M
115.73 M
Profit Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
EBITDA
(78.88 M)
(9.88 M)
(96.85 M)
(83.58 M)
(8.05 M)
(68.42 M)
(23.58 M)
(59.53 M)
(81.31 M)
(14.95 M)
Operating Margin
N/A
-9.82
N/A
N/A
N/A
N/A
-22.36
-21.42
N/A
-45.35
Current Valuation
(82.12 M)
74.65 M
716.91 M
74.78 M
35.94 M
189.32 M
34.52 M
41.58 M
(11.38 M)
22.07 M
Price To Book
0.44
2.12
3.32
1.42
19.67
2.61
2.8
1.26
0.95
1.71
Retained Earnings
(310 M)
(415.7 M)
(265.92 M)
(181.48 M)
(65.4 M)
(329.44 M)
(70.53 M)
(191.75 M)
(163.42 M)
(277.75 M)
Current Asset
N/A
22.73 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
1.48
0.77
-3.14
1.76
-1.01
1.19
0.84
0.54
1.0
0.58
Number Of Employees
63
13
83
76
2
59
45
167
51
174
Shares Outstanding
51.75 M
49.05 M
54.23 M
32.6 M
25.93 M
57.94 M
37.82 M
36.84 M
28.87 M
44.27 M
Cash Flow From Operations
(55.66 M)
(7.43 M)
(93.05 M)
(69 M)
(8.09 M)
(57.37 M)
(22.51 M)
(59.01 M)
(56.78 M)
(28.45 M)
Total Debt
13.29 M
215.93 K
238.91 K
20.1 M
260.58 K
2.23 M
6.3 M
3.65 M
675 K
22.31 M
Return On Equity
-0.24
-0.13
-0.45
-0.66
-1.14
-0.58
-3.44
-0.37
-0.82
-0.46
Return On Asset
-0.2
-0.0951
-0.27
-0.35
-0.66
-0.34
-0.7
-0.21
-0.49
-0.2
Number Of Shares Shorted
846.9 K
351.75 K
183.25 K
743.27 K
6.51 K
1.08 M
144.73 K
57.95 K
1.89 M
1.51 K
Book Value Per Share
3.82
1.27
7.35
4.22
0.15
2.27
-0.17
4.18
2.79
1.28
Current Liabilities
N/A
1.49 M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
252.15 M
66.27 M
398.69 M
143.05 M
4.07 M
132.74 M
28.51 M
198.35 M
127.42 M
115.73 M
Debt To Equity
0.045
0.01
0.001
N/A
N/A
0.001
0.005
0.02
0.008
0.15
Short Ratio
3.93
11.2
1.49
6.48
1.94
3.16
0.28
1.61
1.11
0.33
Target Price
5.8
8.33
33.1
16.2
6.0
13.0
3.0
9.33
2.33
10.54
Shares Owned By Institutions
80.88
21.3
87.5
96.3
28.18
64.24
3.1
5.31
99.98
25.54
Market Capitalization
87.45 M
112.81 M
1.07 B
206.98 M
42.79 M
310 M
11.95 M
201.26 M
76.81 M
108.46 M
Price To Earnings To Growth
-0.31
-0.94
-0.12
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Price To Earning
N/A
-24.69
N/A
N/A
N/A
N/A
N/A
1.85
0.64
N/A
Price To Sales
N/A
112.81
N/A
N/A
N/A
N/A
5.79
33.53
N/A
126.45
Net Income
(68.96 M)
(8.57 M)
(99.83 M)
(78.63 M)
(8.2 M)
(68.46 M)
(24.99 M)
(61.98 M)
(75.52 M)
(18.95 M)
Earnings Per Share
-1.0
-0.21
-2.73
-2.98
-0.32
-1.27
-1.05
-2.14
-2.99
-0.72
Shares Owned By Insiders
2.3
2.98
9.49
0.018
64.22
13.74
52.3
N/A
0.018
10.65
Revenue
N/A
1000 K
N/A
N/A
N/A
N/A
2.84 M
7.04 M
N/A
18.11 M
Working Capital
193.38 M
47.9 M
383.25 M
95.15 M
3.25 M
119.05 M
(2.34 M)
178.04 M
106.59 M
81.99 M
Cash And Equivalents
277.43 M
65.23 M
201.38 M
218.82 M
14.55 M
150.41 M
32.41 M
267.13 M
151.99 M
168.04 M
Cash Per Share
6.08
1.33
5.96
9.26
0.62
3.87
0.9
8.22
6.22
3.87
Gross Profit
N/A
4.04 M
N/A
N/A
N/A
N/A
4.1 M
138.85 M
N/A
10.18 M
Day Typical Price
1.65
2.23
19.96
6.11
1.53
5.21
0.43
5.83
2.58
2.23
Accumulation Distribution
7517.86
3878.18
8603.99
27641.6
0.0943
27297.58
58822.61
76.11
14224.49
12928.65
Market Facilitation Index
0.0
0.0
0.0
0.0
0.15
0.0
N/A
0.0
N/A
0.0
Daily Balance Of Power
0.875
(0.29)
0.2056
(0.35)
0.7333
(0.44)
(0.80)
3.2
(0.64)
(0.74)
Period Momentum Indicator
0.07
(0.04)
0.22
(0.34)
0.11
(0.19)
(0.04)
0.32
(0.07)
(0.14)
Rate Of Daily Change
1.04
0.98
1.01
0.95
1.08
0.96
0.91
1.06
0.97
0.94
Day Median Price
1.64
2.22
19.95
6.16
1.52
5.24
0.44
5.83
2.6
2.26
Price Action Indicator
0.075
0.02
0.16
(0.32)
0.09
(0.17)
(0.04)
0.16
(0.08)
(0.14)
Relative Strength Index
46.62
54.04
44.11
24.83
40.12
40.43
74.45
47.14
62.19
35.58
Coefficient Of Variation
3644.94
876.38
1833.74
(1,062)
24012.06
1623.31
1286.79
4036.03
677.65
(7,764)
Mean Deviation
1.66
4.83
3.08
3.43
4.9
2.83
13.27
4.36
2.39
4.5
Jensen Alpha
(0)
1.19
0.0552
(0.63)
(0.11)
0.1105
3.57
0.0075
0.4154
(0.12)
Total Risk Alpha
(0.28)
(0.19)
(0.36)
(1.21)
(1.17)
(0.32)
(2.41)
(0.79)
0.0331
(0.93)
Sortino Ratio
(0.02)
0.1594
0.03
N/A
(0.01)
0.0441
0.3121
0.012
0.162
N/A
Downside Variance
6.71
26.67
16.25
N/A
63.21
11.24
100.14
25.61
6.42
N/A
Standard Deviation
2.5
8.21
4.3
5.21
8.83
4.24
41.65
7.02
3.55
6.23
Kurtosis
2.44
17.57
1.31
5.38
14.4
9.84
58.93
14.07
4.62
1.89
Potential Upside
4.32
12.43
7.76
6.69
8.61
6.8
22.0
9.38
5.58
8.13
Treynor Ratio
0.1015
(0.36)
0.1371
(0.39)
0.021
0.1844
(0.98)
0.1083
0.5392
(0.34)
Maximum Drawdown
13.98
61.3
23.21
26.81
76.0
30.01
352.85
52.92
19.11
37.93
Variance
6.27
67.39
18.49
27.19
78.04
17.99
1734.67
49.3
12.6
38.81
Market Risk Adjusted Performance
0.1115
(0.35)
0.1471
(0.38)
0.031
0.1944
(0.97)
0.1183
0.5492
(0.33)
Risk Adjusted Performance
0.0279
0.0961
0.0498
(0.06)
0.0123
0.0552
0.0691
0.0278
0.1204
(0)
Skewness
0.6497
3.27
(0.14)
(0.47)
1.92
2.09
7.48
2.68
1.63
(0.63)
Semi Deviation
2.11
4.29
3.78
N/A
7.16
3.11
8.38
4.65
2.09
N/A
Information Ratio
(0.02)
0.1003
0.0282
(0.12)
(0.01)
0.0349
0.075
0.0086
0.1156
(0.03)
Value At Risk
(4.43)
(8.50)
(7.49)
(9.02)
(11.48)
(5.54)
(16.67)
(7.22)
(3.86)
(9.52)
Expected Short fall
(2.03)
(6.59)
(3.60)
N/A
(5.82)
(3.27)
(22.88)
(5.93)
(3.24)
N/A
Downside Deviation
2.59
5.16
4.03
N/A
7.95
3.35
10.01
5.06
2.53
N/A
Semi Variance
4.47
18.4
14.3
N/A
51.21
9.65
70.16
21.59
4.38
N/A

Multicell Techs Competition Performance Charts

Five steps to successful analysis of Multicell Techs Competition

Multicell Techs' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Multicell Techs in relation to its competition. Multicell Techs' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Multicell Techs in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Multicell Techs' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Multicell Techs, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Multicell Techs position

In addition to having Multicell Techs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Biotech Thematic Idea Now

Biotech
Biotech Theme
Companies specialized in biotechnology production and delivery of pharmaceuticals services. The Biotech theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Biotech Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Multicell Pink Sheet Analysis

When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY